Furthermore, TP53 mutations are known to be more prevalent in HR+/HER2- BC with the PAM50-basal intrinsic subtype and are associated with a higher infiltration of CD8+ T cells and B cells [62,63]. The gene discussed is ERBB2; the disease is breast cancer.